ES551410A0 - Procedimiento de preparar derivados rodaninicos. - Google Patents

Procedimiento de preparar derivados rodaninicos.

Info

Publication number
ES551410A0
ES551410A0 ES551410A ES551410A ES551410A0 ES 551410 A0 ES551410 A0 ES 551410A0 ES 551410 A ES551410 A ES 551410A ES 551410 A ES551410 A ES 551410A ES 551410 A0 ES551410 A0 ES 551410A0
Authority
ES
Spain
Prior art keywords
rhodaninic
derivatives
preparing
procedure
rhodaninic derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES551410A
Other languages
English (en)
Other versions
ES8704486A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of ES8704486A1 publication Critical patent/ES8704486A1/es
Publication of ES551410A0 publication Critical patent/ES551410A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Catalysts (AREA)
ES551410A 1985-07-10 1986-01-15 Procedimiento de preparar derivados rodaninicos. Expired ES8704486A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60152632A JPS6212776A (ja) 1985-07-10 1985-07-10 ロ−ダニン誘導体

Publications (2)

Publication Number Publication Date
ES8704486A1 ES8704486A1 (es) 1987-04-16
ES551410A0 true ES551410A0 (es) 1987-04-16

Family

ID=15544630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES551410A Expired ES8704486A1 (es) 1985-07-10 1986-01-15 Procedimiento de preparar derivados rodaninicos.

Country Status (8)

Country Link
US (2) US4714765A (es)
EP (2) EP0258914A3 (es)
JP (1) JPS6212776A (es)
KR (1) KR910006638B1 (es)
AU (1) AU556518B1 (es)
CA (1) CA1264758A1 (es)
DE (1) DE3583803D1 (es)
ES (1) ES8704486A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
US4897406A (en) * 1987-11-13 1990-01-30 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
JP2835545B2 (ja) * 1990-11-27 1998-12-14 株式会社大塚製薬工場 白内障予防及び治療剤
JP2835547B2 (ja) * 1991-12-25 1998-12-14 株式会社大塚製薬工場 糖尿病治療剤
NZ248573A (en) * 1992-09-10 1996-02-27 Lilly Co Eli 5-arylmethyl (and methylidene) thiazolidin-4-one derivatives; their preparation and pharmaceutical compositions
US6251928B1 (en) * 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
JP3923079B2 (ja) * 1995-07-31 2007-05-30 塩野義製薬株式会社 ホスホリパーゼａ２阻害活性を有するピロリジン誘導体
WO2000018747A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
WO2002040458A1 (fr) * 2000-11-17 2002-05-23 Takeda Chemical Industries, Ltd. Derives d'isoxazole
KR101095734B1 (ko) 2009-01-23 2011-12-21 숙명여자대학교산학협력단 신규한 로다닌 유도체와 이의 의약적 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB489335A (en) * 1937-01-22 1938-07-22 Douglas James Fry Improvements in or relating to the manufacture and use of dyestuffs suitable for sensitising photographic emulsions
SU467058A1 (ru) * 1973-09-20 1975-04-15 Московский Ордена Трудового Красного Знамени Институт Нефтехимической И Газовой Промышленности Им.И.М.Губкина Способ получени смеси бисфенолов
JPS5430171A (en) * 1977-08-10 1979-03-06 Taiho Pharmaceutical Co Ltd Isooxazole derivative and production
JPS5728074A (en) 1980-07-28 1982-02-15 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation, and inhibitor for aldose reducing enzyme consisting essentially of it
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPS6127984A (ja) * 1984-07-16 1986-02-07 Taiho Yakuhin Kogyo Kk ロ−ダニン酢酸誘導体
JPH0638665B2 (ja) * 1985-07-08 1994-05-18 松下電器産業株式会社 リニア信号処理回路

Also Published As

Publication number Publication date
EP0208040B1 (en) 1991-08-14
AU556518B1 (en) 1986-11-06
CA1264758A1 (en) 1990-01-23
US4714765A (en) 1987-12-22
CA1266273C (es) 1990-02-27
KR870001204A (ko) 1987-03-12
ES8704486A1 (es) 1987-04-16
JPH0574591B2 (es) 1993-10-18
EP0258914A2 (en) 1988-03-09
DE3583803D1 (de) 1991-09-19
KR910006638B1 (ko) 1991-08-29
JPS6212776A (ja) 1987-01-21
EP0208040A2 (en) 1987-01-14
US4777259A (en) 1988-10-11
EP0258914A3 (en) 1988-11-17
EP0208040A3 (en) 1988-03-16

Similar Documents

Publication Publication Date Title
NO860226L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1,4-dihydro-4-oksonaftyridin-derivater.
ES555815A0 (es) Procedimiento de obtencion de derivados de mitomicina.
NO851921L (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifanycin-derivater.
NO167034C (no) Fremgangsmaate for fremstilling av 1,6-diklor-1,6-dideoksy-beta-d-fruktofuranosyl-4-kloro-4-dioksy-alfa-galactopyranosid
NO872831D0 (no) Fremgangsmaate for fremstilling av nitrofuranderivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO863608L (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
ES2032299T3 (es) Procedimiento para obtener derivados de metil-penicilina 3-beta-sustituida.
NO862860D0 (no) Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater.
ES555546A0 (es) Procedimiento para preparar derivados de cinalina.
ES557692A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES557730A0 (es) Procedimientopara la preparacion de derivados de 2-oxi-4h-3, 1-ebzoxazin-4-ona
ES551410A0 (es) Procedimiento de preparar derivados rodaninicos.
ES553851A0 (es) Procedimiento para preparar derivados de nitrofurano
ES551481A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO167159C (no) Fremgangsmaate for fremstilling av cellulosemasse.
AR240319A1 (es) Procedimiento de preparacion de n-sulfamil-3-(2-guanidino-tiazol-4-il-metiltio)-propionamidina.
ES555384A0 (es) Procedimiento de preparar diosmina
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
ES544581A0 (es) Procedimiento para preparar derivados de isoquinolina.
ES554828A0 (es) Procedimiento para preparar derivados de fluoralcanos.
ES551777A0 (es) Procedimiento de preparacion de derivados de 3-hidroxi-3-fenilpiperidina
ES555036A0 (es) Procedimiento para preparar derivados de oxadiazolilimidazobenzodiazepina